GlaxoSmithKline PLC (GSK) Social Stream
GSK PLC (GSK) Price Targets From Analysts
Use the tables below to see what analysts covering GSK PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $52.5 | $41.5 | $47.75 | $30.01 | 59.11% |
| 2022-01-03 | 8 | $51 | $41.5 | $47.375 | $30.01 | 57.86% |
| 2022-01-17 | 7 | $51 | $44.2 | $48.733 | $30.01 | 62.39% |
| 2022-02-02 | 7 | $52.5 | $44.2 | $49.233 | $30.01 | 64.06% |
| 2022-02-14 | 7 | $52.5 | $46.3 | $49.933 | $30.01 | 66.39% |
| 2022-03-14 | 7 | $51.5 | $45.6 | $49.366 | $30.01 | 64.5% |
| 2022-04-05 | 7 | $55 | $45.6 | $50.533 | $30.01 | 68.39% |
| 2022-04-19 | 7 | $55 | $45.7 | $50.566 | $30.01 | 68.5% |
| 2022-04-21 | 7 | $55 | $44.5 | $50.166 | $30.01 | 67.16% |
| 2022-04-27 | 7 | $55 | $45.9 | $50.633 | $30.01 | 68.72% |
| 2022-05-31 | 6 | $52.5 | $45.9 | $49.8 | $30.01 | 65.94% |
| 2022-06-07 | 7 | $52.5 | $45.9 | $49.8 | $30.01 | 65.94% |
| 2022-06-16 | 7 | $51 | $45.9 | $49.133 | $30.01 | 63.72% |
| 2022-07-26 | 7 | $63.125 | $44.4 | $52.841 | $30.01 | 76.08% |
| 2022-08-13 | 7 | $63.125 | $43.5 | $52.541 | $30.01 | 75.08% |
| 2022-08-24 | 7 | $63.125 | $36 | $50.041 | $30.01 | 66.75% |
| 2022-09-19 | 7 | $51 | $34 | $40.333 | $30.01 | 34.4% |
The Trend in the Analyst Price Target
Over the past 35 weeks, GSK's average price target has gone down $8.4.
Over the past 45 weeks, GSK's average upside potential has been 16.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | 52.500 | 41.5 | 47.750 | 43.49 | 9.8% |
| 2022-01-03 | 7 | 51.000 | 41.5 | 47.833 | 43.67 | 9.53% |
| 2022-04-19 | 7 | 55.000 | 45.7 | 50.566 | 45.89 | 10.19% |
| 2022-07-28 | 7 | 63.125 | 43.5 | 52.541 | 42.93 | 22.39% |
| 2022-08-13 | 7 | 63.125 | 43.5 | 52.541 | 36.03 | 45.83% |
GSK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 7 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
GSK's average broker recommendation rating worsened by 0.25 over the prior 43 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GSK as an investment opportunity.
- In the context of all US stocks, GSK PLC's variance in analysts' estimates is lower than -326.76% of them.
- GSK PLC's number of analysts covering the stock is higher than 270.51% of stocks in the large market cap category.
- GSK has a greater upside potential (average analyst target price relative to current price) than 438.26% of Pharmaceutical Products stocks.
- GSK has a higher average analyst price target than 477.89% of stocks in the large market cap category.
In the Pharmaceutical Products industry, GRFS, GMAB, and GLPG are the three stocks most similar to GSK PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding GSK using the data that counts. Try POWR Ratings for free.